Icosavax Reports First Quarter 2023 Financial Results and Provides Corporate Update
10 mai 2023 16h05 HE
|
Icosavax, Inc.
- IVX-A12 (RSV+hMPV) Phase 1 topline interim data expected in 2Q 2023 - - Initiation of IVX-A12 Phase 2 trial expected in 2H 2023 - - Cash and cash equivalents, restricted cash, and short-term...
Recombinant proteins market is projected to grow at a CAGR of 11.14% by 2033: Visiongain Reports Ltd
05 mai 2023 11h43 HE
|
Visiongain Reports Ltd
Visiongain has published a new report: Recombinant Proteins Market: Forecasts by Products & Services (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILS), Others), Antibodies,...
Recombinant proteins market is projected to grow at a CAGR of 11.14% by 2033: Visiongain Reports Ltd
20 avr. 2023 11h52 HE
|
Visiongain Reports Ltd
Visiongain has published a new report: Recombinant Proteins Market:- Forecasts by Products & Services (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILS), Others), Antibodies,...
WellSpan Health and Helix announce partnership to improve patient health outcomes through new population genomics program
08 déc. 2022 08h50 HE
|
WellSpan Health
York, Pa., Dec. 08, 2022 (GLOBE NEWSWIRE) -- WellSpan Health and Helix, the nation’s leading population genomics and viral surveillance company, announced today a partnership to create a...
AB Science - Positive recommendation of the Data and Safety Monitoring Board to continue the Phase 2 study evaluating the antiviral activity of masitinib in Covid-19
14 sept. 2022 12h21 HE
|
AB Science
PRESS RELEASE POSITIVE RECOMMENDATION OF THE DATA AND SAFETY MONITORING BOARD TO CONTINUE THE PHASE 2 STUDY EVALUATING ANTIVIRAL ACTIVITY OF MASITINIB IN COVID-19 Paris, 14 September 2022,...
AB Science - Recommandation favorable du comité indépendant de revue des données de poursuivre l’étude de Phase 2 évaluant l’activité antivirale du masitinib dans le traitement du Covid-19
14 sept. 2022 12h21 HE
|
AB Science
COMMUNIQUE DE PRESSE RECOMMANDATION FAVORABLE DU COMITE INDEPENDANT DE REVUE DES DONNEES DE POURSUIVRE L’ETUDE DE PHASE 2 EVALUANT L’ACTIVITE ANTIVIRALE DU MASITINIB DANS LE TRAITEMENT DU COVID-19 ...
The Animal Protection Party of Canada says CFIA Abdicates Responsibility Over African Swine Fever to Industry
28 mars 2022 13h57 HE
|
Animal Protection Party of Canada
TORONTO, March 28, 2022 (GLOBE NEWSWIRE) -- The Animal Protection Party of Canada is raising the alarm over the federal government’s proposed National Compartmentalization Program (NCP) for African...
$10 Million+ Class-Action Lawsuit Seeks Damages From CareCube’s Scheme to Overcharge for COVID-19 Tests
23 févr. 2022 14h44 HE
|
WMP Law
NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Armonk, New York-based law firm Wittels McInturff Palikovic (WMP) filed a lawsuit in Kings County Supreme Court to recover tens of millions of dollars for...
Vystar Adds Vytex into RxAir Spin-off, Sets Spin-Off Record Date, Opens Opportunity for Reverse Merger Into Vystar/Rotmans
23 févr. 2022 07h55 HE
|
Vystar Corp.
Vystar/Rotmans would have singular focus on furniture/bedding industry to be attractive reverse merger opportunityRxAir NewCo would include RxAir®, Vytex® and Fluid Energy ConversionRxAir NewCo...
LSU CEE Professor Bivins Studying Wastewater on International Flights
07 févr. 2022 11h00 HE
|
LSU College of Engineering
BATON ROUGE, La., Feb. 07, 2022 (GLOBE NEWSWIRE) -- With the COVID-19 Omicron variant spreading like wildfire, testing has never been more important. This is why LSU Civil & Environmental...